tiprankstipranks
Advertisement
Advertisement

HK:2487 Stock Latest News

Cutia Therapeutics Sets Board Meeting to Approve Interim Results and Consider Dividend
Company AnnouncementsCutia Therapeutics Sets Board Meeting to Approve Interim Results and Consider Dividend
2m ago
2487
Cutia Therapeutics Wins Shareholder Backing for All AGM Resolutions
PremiumCompany Announcements
Cutia Therapeutics Wins Shareholder Backing for All AGM Resolutions
2M ago
2487
Cutia Wins NMPA Nod for Topical Anesthesia Cream, Expanding China Dermatology Portfolio
PremiumCompany Announcements
Cutia Wins NMPA Nod for Topical Anesthesia Cream, Expanding China Dermatology Portfolio
3M ago
2487
Cutia Therapeutics Changes Cayman Share Registrar Name Without Moving Registered Office
PremiumCompany Announcements
Cutia Therapeutics Changes Cayman Share Registrar Name Without Moving Registered Office
4M ago
2487
Cutia Therapeutics Sets 2026 AGM to Vote on Board, Auditor and Share Mandates
PremiumCompany Announcements
Cutia Therapeutics Sets 2026 AGM to Vote on Board, Auditor and Share Mandates
4M ago
2487
Cutia Therapeutics’ Botox Rival Meets Phase III Goals in China
PremiumCompany AnnouncementsCutia Therapeutics’ Botox Rival Meets Phase III Goals in China
4M ago
2487
Cutia Therapeutics Boosts Revenue and Margins as Key Dermatology Products Launch in 2025
Premium
Company Announcements
Cutia Therapeutics Boosts Revenue and Margins as Key Dermatology Products Launch in 2025
5M ago
2487
Cutia Therapeutics Wins China Trial Nod for New Topical Hair-Loss Drug
Premium
Company Announcements
Cutia Therapeutics Wins China Trial Nod for New Topical Hair-Loss Drug
5M ago
2487
Cutia Therapeutics Sets March 2026 Board Meeting to Approve 2025 Annual Results
PremiumCompany Announcements
Cutia Therapeutics Sets March 2026 Board Meeting to Approve 2025 Annual Results
5M ago
2487
Cutia Therapeutics’ Botulinum Toxin CU-20101 Meets Phase III Goals in China
PremiumCompany Announcements
Cutia Therapeutics’ Botulinum Toxin CU-20101 Meets Phase III Goals in China
7M ago
2487
Cutia Therapeutics Reshapes Board with Resignation of Dr. Huang and Appointment of Veteran Executive Lu Minfang
PremiumCompany Announcements
Cutia Therapeutics Reshapes Board with Resignation of Dr. Huang and Appointment of Veteran Executive Lu Minfang
8M ago
2487
Cutia Therapeutics Updates Board and Committee Structure
PremiumCompany Announcements
Cutia Therapeutics Updates Board and Committee Structure
8M ago
2487
Cutia Therapeutics’ Topical Finasteride Spray Gains Regulatory Acceptance
PremiumCompany AnnouncementsCutia Therapeutics’ Topical Finasteride Spray Gains Regulatory Acceptance
9M ago
2487
Cutia Therapeutics’ Acne Treatment Shows Promising Early Results
Premium
Company Announcements
Cutia Therapeutics’ Acne Treatment Shows Promising Early Results
9M ago
2487
Cutia Therapeutics Completes HK$240 Million Share Placement
Premium
Company Announcements
Cutia Therapeutics Completes HK$240 Million Share Placement
12M ago
2487
Cutia Therapeutics to Raise HK$240 Million Through Share Placement
PremiumCompany Announcements
Cutia Therapeutics to Raise HK$240 Million Through Share Placement
12M ago
2487
Cutia Therapeutics Announces Board Changes
PremiumCompany Announcements
Cutia Therapeutics Announces Board Changes
12M ago
2487
Cutia Therapeutics Announces Board Composition and Committee Roles
PremiumCompany Announcements
Cutia Therapeutics Announces Board Composition and Committee Roles
12M ago
2487
Cutia Therapeutics Forms Nomination Committee to Enhance Governance
PremiumCompany Announcements
Cutia Therapeutics Forms Nomination Committee to Enhance Governance
12M ago
2487
Cutia Therapeutics Announces Key Administrative Changes and Office Relocation
PremiumCompany AnnouncementsCutia Therapeutics Announces Key Administrative Changes and Office Relocation
12M ago
2487
Cutia Therapeutics Advances in Dermatology with New Product Approvals
Premium
Company Announcements
Cutia Therapeutics Advances in Dermatology with New Product Approvals
12M ago
2487
Cutia Therapeutics Schedules Board Meeting for Interim Results Review
Premium
Company Announcements
Cutia Therapeutics Schedules Board Meeting for Interim Results Review
1y ago
2487

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >